Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Depreciation & Amortization (CF) (2020 - 2025)

BioAtla's Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $19000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 91.67% year-over-year to $19000.0; the TTM value through Dec 2025 reached $373000.0, down 59.68%, while the annual FY2025 figure was $373000.0, 59.68% down from the prior year.
  • Depreciation & Amortization (CF) reached $19000.0 in Q4 2025 per BCAB's latest filing, down from $56000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $380000.0 in Q3 2021 to a low of $19000.0 in Q4 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $252400.0, with a median of $289000.0 recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): surged 52.09% in 2021, then tumbled 91.67% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $314000.0 in 2021, then fell by 5.1% to $298000.0 in 2022, then rose by 23.49% to $368000.0 in 2023, then tumbled by 38.04% to $228000.0 in 2024, then crashed by 91.67% to $19000.0 in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Depreciation & Amortization (CF) are $19000.0 (Q4 2025), $56000.0 (Q3 2025), and $115000.0 (Q2 2025).